Clinical Trial Update: Phase 2 Study of Erlotinib, Gemcitabine and Oxaliplatin Combination Chemotherapy to Advanced Pancreatic Cancer [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating the combination of erlotinib, gemcitabine, and oxaliplatin for advanced pancreatic cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Drugs mentioned

• ERLOTINIB (Erlotinib)
• Gemcitabine (Gemcitabine)
• OXALIPLATIN (Oxaliplatin)

Snippet

Sponsor: Soonchunhyang University Hospital | Conditions: Pancreatic Cancer | Phase 2 | Status: COMPLETED